Angiotensin-converting enzyme inhibition limits dysfunction in adjacent noninfarcted regions during left ventricular remodeling.

[1]  T. Parrish,et al.  Bradykinin antagonism inhibits the antigrowth effect of converting enzyme inhibition in the dog myocardium after discrete transmural myocardial necrosis. , 1995, Circulation.

[2]  B. Jugdutt,et al.  Effect of enalapril on ventricular remodeling and function during healing after anterior myocardial infarction in the dog. , 1995, Circulation.

[3]  J. Cohn,et al.  Angiotensin-converting enzyme inhibition and beta-adrenoceptor blockade regress established ventricular remodeling in a canine model of discrete myocardial damage. , 1994, Journal of the American College of Cardiology.

[4]  H. Schunkert,et al.  Angiotensin‐Converting Enzyme Inhibition Prolongs Survival and Modifies the Transition to Heart Failure in Rats With Pressure Overload Hypertrophy Due to Ascending Aortic Stenosis , 1994, Circulation.

[5]  L. Axel,et al.  Regional Heterogeneity of Function in Hypertrophic Cardiomyopathy , 1994, Circulation.

[6]  Gruppo Italiano per lo Studio della Soprawivenza nell'Inf Miocardico..  GISSI-3: effects of lisiriopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction , 1994, The Lancet.

[7]  G. Lamas,et al.  Quantitative Two-Dimensional Echocardiographic Measurements are Major Predictors of Adverse Cardiovascular Events After Acute Myocardial Infarction: The Protective Effect of Captopril , 1994, Circulation.

[8]  H. Drexler,et al.  Comparative effects of chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on cardiac remodeling after myocardial infarction in the rat. , 1994, Circulation.

[9]  Importance of sympathetic innervation in the positive inotropic effects of bradykinin and ramiprilat. , 1994, Circulation research.

[10]  G. Murray,et al.  Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators , 1993 .

[11]  L Axel,et al.  Regional differences in function within noninfarcted myocardium during left ventricular remodeling. , 1993, Circulation.

[12]  W. Linz,et al.  Ramiprilat increases bradykinin outflow from isolated hearts of rat , 1993, British journal of pharmacology.

[13]  E. J. Brown,et al.  Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. , 1992, The New England journal of medicine.

[14]  G. Lamas,et al.  Left ventricular remodeling in the year after first anterior myocardial infarction: a quantitative analysis of contractile segment lengths and ventricular shape. , 1992, Journal of the American College of Cardiology.

[15]  B. Jugdutt,et al.  Effect of long-term captopril therapy on left ventricular remodeling and function during healing of canine myocardial infarction. , 1992, Journal of the American College of Cardiology.

[16]  L Axel,et al.  Circumferential Myocardial Shortening in the Normal Human Left Ventricle: Assessment by Magnetic Resonance Imaging Using Spatial Modulation of Magnetization , 1991, Circulation.

[17]  E. Sonnenblick,et al.  Cellular basis of chronic ventricular remodeling after myocardial infarction in rats. , 1991, Circulation research.

[18]  K. Baker,et al.  Angiotensin II stimulation of protein synthesis and cell growth in chick heart cells. , 1990, The American journal of physiology.

[19]  J. Bavaria,et al.  Large animal model of left ventricular aneurysm. , 1989, The Annals of thoracic surgery.

[20]  L. Axel,et al.  MR imaging of motion with spatial modulation of magnetization. , 1989, Radiology.

[21]  E. Zerhouni,et al.  Human heart: tagging with MR imaging--a method for noninvasive assessment of myocardial motion. , 1988, Radiology.

[22]  B. Jugdutt,et al.  Intravenous nitroglycerin therapy to limit myocardial infarct size, expansion, and complications. Effect of timing, dosage, and infarct location. , 1988, Circulation.

[23]  R M Whitlock,et al.  Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. , 1987, Circulation.

[24]  W Grossman,et al.  Left ventricular remodeling after myocardial infarction: a corollary to infarct expansion. , 1986, Circulation.

[25]  M. Pfeffer,et al.  Survival after an experimental myocardial infarction: beneficial effects of long-term therapy with captopril. , 1985, Circulation.

[26]  M. Pfeffer,et al.  Influence of Chronic Captopril Therapy on the Infarcted Left Ventricle of the Rat , 1985, Circulation research.

[27]  J. Weiss,et al.  Late effects of acute infarct dilation on heart size: a two dimensional echocardiographic study. , 1982, The American journal of cardiology.

[28]  M. Pfeffer,et al.  Myocardial Infarct Size and Ventricular Function in Rats , 1979, Circulation research.

[29]  K. Hammermeister,et al.  Variables predictive of survival in patients with coronary disease. Selection by univariate and multivariate analyses from the clinical, electrocardiographic, exercise, arteriographic, and quantitative angiographic evaluations. , 1979, Circulation.

[30]  J. B. Garrison,et al.  Regional cardiac dilatation after acute myocardial infarction: recognition by two-dimensional echocardiography. , 1979, The New England journal of medicine.